Literature DB >> 1359901

Inhibition of specific pathways of myeloid cell differentiation by an activated Hox-2.4 homeobox gene.

C Blatt1, J Lotem, L Sachs.   

Abstract

Abnormal expression of homeobox genes is one of the abnormalities associated with the development of murine and human leukemia. Myeloid leukemic cells that can be induced to differentiate to mature cells by interleukin 6 were stably transfected with an activated Hox-2.4 homeobox gene. Expression of the Hox-2.4 gene in the transfected clones inhibited specific pathways of the myeloid differentiation program induced by interleukin 6. The expression of some genes associated with differentiation was almost completely blocked, and the expression of other genes was either partially inhibited or not affected. The results support the hypothesis that abnormal expression of Hox-2.4 may contribute to the development of leukemia by interfering with the differentiation program.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1359901

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  10 in total

1.  HOXC4, HOXC5, and HOXC6 expression in primary cutaneous lymphoid lesions. High expression of HOXC5 in anaplastic large-cell lymphomas.

Authors:  J J Bijl; E Rieger; J W van Oostveen; J M Walboomers; M Kreike; R Willemze; C J Meijer
Journal:  Am J Pathol       Date:  1997-10       Impact factor: 4.307

2.  Characterization of the 3' untranslated region of the mouse homeobox gene HoxB5.

Authors:  C C Yu; C J Paige; G E Wu
Journal:  Experientia       Date:  1995-06-14

Review 3.  Hox genes in the lung.

Authors:  C Kappen
Journal:  Am J Respir Cell Mol Biol       Date:  1996-08       Impact factor: 6.914

Review 4.  Transcriptional regulation during myelopoiesis.

Authors:  N Lenny; J J Westendorf; S W Hiebert
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

5.  Oncogenic HOXB8 is driven by MYC-regulated super-enhancer and potentiates colorectal cancer invasiveness via BACH1.

Authors:  Ying Ying; Yejun Wang; Xiaoyan Huang; Yanmei Sun; Junbao Zhang; Meiqi Li; Junhui Zeng; Maolin Wang; Wenjun Xiao; Lan Zhong; Bo Xu; Lili Li; Qian Tao; Xiaomei Wang; Xing-Sheng Shu
Journal:  Oncogene       Date:  2019-10-07       Impact factor: 9.867

6.  HOXB7 constitutively activates basic fibroblast growth factor in melanomas.

Authors:  A Caré; A Silvani; E Meccia; G Mattia; A Stoppacciaro; G Parmiani; C Peschle; M P Colombo
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

7.  The optimal binding sequence of the Hox11 protein contains a predicted recognition core motif.

Authors:  S Tang; M L Breitman
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

Review 8.  The control of hematopoiesis and leukemia: from basic biology to the clinic.

Authors:  L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

9.  The metabolic regulator mTORC1 controls terminal myeloid differentiation.

Authors:  Pui Y Lee; David B Sykes; Sarah Ameri; Demetrios Kalaitzidis; Julia F Charles; Nathan Nelson-Maney; Kevin Wei; Pierre Cunin; Allyn Morris; Astrid E Cardona; David E Root; David T Scadden; Peter A Nigrovic
Journal:  Sci Immunol       Date:  2017-05-26

10.  Conditional immortalization of mouse myelomonocytic, megakaryocytic and mast cell progenitors by the Hox-2.4 homeobox gene.

Authors:  A C Perkins; S Cory
Journal:  EMBO J       Date:  1993-10       Impact factor: 11.598

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.